Skip to content

Clinical trials

Completed Phase 2 Virus Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Virus Diseases Phase: Phase 2 Status: Completed Clear all

67 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20031
20041
20061
20071
20081
20096
20103
20121
20136
20142
20154
20165
20172
20181
20193
20208
20216
20222
20235
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed67

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline6
Medicago6
ModernaTX, Inc.6
Seqirus4
Gilead Sciences3
Hellenic Institute for the Study of Sepsis3
U.S. Army Medical Research and Development Command3
Merck Sharp & Dohme LLC2
National Institute of Allergy and Infectious Diseases (NIAID)2
Verrica Pharmaceuticals Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Virus Diseases67
RNA Virus Infections15
Infections14
Influenza, Human14
Respiratory Tract Infections14
Respiratory Tract Diseases12
COVID-1910
Coronavirus Infections9
Orthomyxoviridae Infections8
Liver Diseases5

Trials

Showing 1 to 25 of 67. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.